Cough, Cold and Allergy (Hay Fever) Remedies in China

Cough, Cold and Allergy (Hay Fever) Remedies in China

Sales of cough and cold remedies have gradually been normalising in China in 2024, although from a high base established in 2023 during the wave of COVID-19 infections. Persistent respiratory illnesses throughout late 2023 and early 2024 have sustained demand to some extent. However, sales in the summer have underperformed compared with 2023, due to a combination of waning post-COVID-19 demand, and changes in distribution channels.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.